|
|
| Model Number |
8888145015P |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
According to the reporter, during dialysis treatment, it was found that the catheter had a broken blue (venous) luer adapter and hub, with a crack at the broken blue (venous) luer adapter and hub and a leak at the luer adapter.There was nothing unusual observed on the device prior to use.Besides the reported issue, a tear was found on the product at the time of the event.Flushing was done with unremarkable results.The catheter was not repaired and tego was not utilized.There was no excessive force used on the device.The insertion site was treated prior to product placement.There were other products utilized with the device, the customer were using a competitor's extension lines with the catheter and a competitor's caps, and also circuits.The patient was not treated under general or local anesthesia.The cleaning agent used on the entire device was octenisept, and the ointment that was utilized at the exit side was lavanide.The wound dressing utilized was a leukomed patch, which did not include any cleaning agents or antimicrobial properties.The cleaning agent was allowed to dry thoroughly prior to applying ointment to the area and dressing area.The patient was not responsible for any type of catheter maintenance, cleaning, or dressing changes.The cleaning agents were not switched over the life of the catheter, and the cleaning agents were not mixed.The site did not use sepsiderm to clean catheters.There was no protocol change for the recently used cleaning agent.The patient themselves did not use a cleaning agent or antibiotic on the catheter.The customer was using a competitor's extension lines with the catheter and a competitor's caps.There was no blood loss, and blood transfusion was not required due to the event.As a remedial action, the reported product was replaced.There was no intervention required as a result of the event.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: d9, g3, h3, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: d9, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device and a photo were available for evaluation.Visual inspection noted one catheter, with a crack on the threads of its venous luer adapter.It was reported that the luer adapter was leaking and bifurcate was cracked.The reported issues were confirmed.The most likely cause could not be established from the information available.Internal process improvements have been initiated to mitigate this issue.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: g3 correction: b5 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, during dialysis treatment, it was observed that the catheter had a broken blue (venous) luer adapter and hub.It was stated that there was a crack at the venous adapter and hub.There was also a leak at the luer adapter.There was nothing unusual observed on the device prior to use.Besides the reported issue, a tear was found on the product at the time of the event.Flushing was done with unremarkable results.Tego was not utilized.There was no excessive force used on the device.The insertion site was treated prior to product placement.The patient was not treated under general or local anesthesia.There were other products utilized with the device, the customer was using a competitor's extension lines with the catheter and a competitor's caps and also circuits.The cleaning agent used was octenisept.Octenisept was also typically utilized to clean the catheter in its entirety.The ointment that was utilized at the exit side was lavanide.The wound dressing utilized was a leukomed patch, which did not include any cleaning agents or antimicrobial properties.The cleaning agent was allowed to dry thoroughly prior to applying ointment to the area and dressing area.The patient was not responsible for any type of catheter maintenance, cleaning, or dressing changes.The cl eaning agents were not switched over the life of the catheter, and the cleaning agents were not mixed.The site did not use sepsiderm to clean catheters.There was no protocol change for the recently used cleaning agent.The patient themselves did not use a cleaning agent or antibiotic on the catheter.The catheter was not repaired.As a remedial action, the arterial leg was used, and the repo rted product was replaced.There was no blood loss, and blood transfusion was not required due to the event.There was no intervention required as a result of the event.There was no reported patient injury.
|
| |
|
Search Alerts/Recalls
|
|
|